Office capillaroscopy in systemic sclerosis

Clinical Rheumatology - Tập 26 - Trang 1268-1274 - 2006
Murray Baron1,2, Mary Bell3, Arthur Bookman3, Maura Buchignani1, James Dunne4, Marie Hudson1, Dana Jerome3, Sindhu R. Johnson3, Niall Jones5, Elzbieta Kaminska6, Terri Lupton3, Jean-Pierre Mathieu7, Janet Pope8, Russell Steele, Suzanne Taillefer1
1McGill University Montreal, Canada
2Jewish General Hospital, Montreal, Canada
3University of Toronto, Toronto, Canada
4University of British Columbia, Vancouver, Canada
5University of Alberta, Edmonton, Canada
6McMaster University, Hamilton, Canada
7University of Montreal, Montreal, Canada
8University of Western Ontario, London, Canada

Tóm tắt

The aims of this study are to assess the reliability of two office techniques, the ophthalmoscope and the Dermlite® dermatoscope, and to detect nailfold capillaroscopy abnormalities in systemic sclerosis (SSc). Two separate studies were performed. In the first, the nailfolds of two fingers on one hand of 13 SSc patients and two normals were examined by four rheumatologists using an ophthalmoscope. In the second, the nailfolds of the two fingers of each hand of six SSc patients and two normals were examined by six rheumatologists with a Dermlite® dermatoscope. Widefield capillary microscopy was performed by one observer in the ophthalmoscope study to assess validity. The examiners determined the presence or absence of dilated loops, giant capillary loops, and/or avascular areas on each digit. The kappa coefficient was calculated to demonstrate agreement. With the ophtalmoscope, the inter-observer kappa coefficients were 0.43, 0.54, and 0.19; the average intra-observer agreements were 0.61, 0.56, and 0.31; and the ophthalmoscope–microscope agreement were 0.63, 0.52, and <0.1 for dilated capillaries, giant capillaries, and avascular areas, respectively. With the dermatoscope, the kappa values for inter-observer reliability were 0.63, 0.40, and 0.20; and intra-observer reliability was 0.71, 0.55, and 0.40 for dilated capillaries, giant capillaries, and avascular areas, respectively. The ophthalmoscope and the dermatoscope provide moderate to substantial reliability to detect the presence of giant and dilated capillaries but poor inter-observer agreement for avascular areas. The ophthalmoscope is valid when compared to the microscope for detecting giant or dilated capillaries. We conclude that these techniques are useful office tools to detect capillary abnormalities in SSc.

Tài liệu tham khảo

Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628 Maricq HR, Spencer-Green G, Leroy EC (1975) Abnormal capillary patterns and systemic disease in scleroderma (progressive systemic sclerosis). Bibl Anat 13:248–249 Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud’s syndrome and dermatomyositis. Am J Med 61:862–870 Maricq HR (1978) In vivo capillary microscopy for the clinician. Arthritis Rheum 21:173 Maricq HR (1981) Wide-field capillary microscopy. Arthritis Rheum 24:1159–1165 Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160 Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736 Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590 Herd JK (1976) Nailfold capillary microscopy made easy. Arthritis Rheum 19:1370–1371 Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409 Minkin W, Rabhan NB (1982) Office nail fold capillary microscopy using ophthalmoscope. J Am Acad Dermatol 7:190–193 Ranft J, Lammersen T, Heidrich H (1987) In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma. Arthritis Rheum 30:1173–1175 Bauersachs RM (1997) The poor man’s capillary microscope. A novel technique for the assessment of capillary morphology. Ann Rheum Dis 56:435–437 Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030 Chen ZY, Silver RM, Ainsworth SK et al (1984) Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 77:812–822 Maricq HR (1992) Capillary abnormalities, Raynaud’s phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol 128:630–632 Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16:75–91 Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205 Maricq HR, Maize JC (1982) Nailfold capillary abnormalities. Clin Rheum Dis 8:455–478 Maricq HR, Weinberger AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud’s phenomenon. J Rheumatol 9:289–291 Kenik JG, Maricq HR, Bole GG (1981) Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum 24:885–891 Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183–189 Maricq HR (1977) Variations in the skin microvascular patterns of the hand. Bibl Anat 16:164–169 Arpaia G, Cimminiello C, Milani M et al (1989) A new capillaroscopic assessment of microvascular damage vs Maricq classification in patients with isolated Raynaud phenomenon. Int Angiol 8:129–133 Maricq HR (1970) “Wide-field” photography of nailfold capillary bed and a scale of plexus visualization scores (PVS). Microvasc Res 2:335–340 Conger AJ (1980) Integration and generalisation of kappas for multiple raters. Psychol Bull 88:322–328 Portney L, Watkins M (2000) Foundations of clinical research: applications to practice. Prenrice-Hall, New Jersey, pp 568–570 Walter SD, Eliasziw M, Donner A (1998) Sample size and optimal designs for reliability studies. Stat Med 17:101–110 Maricq HR (1966) Capillary morphology and the course of illness in schizophrenic patients. J of Nerv Ment Dis 142:63–71 Wildt M, Hesselstrand R, Scheja A et al (1999) Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol 17:219–222 Lee P, Leung FY, Alderdice C et al (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938 Tooth LR, Ottenbacher KJ (2004) The kappa statistic in rehabilitation research: an examination. Arch Phys Med Rehabil 85:1371–1376 Hoehler FK (2000) Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol 53:499–503